What a pain management clinic typically checks before adding a vendor
Pain management and physical medicine practices generally run vendor qualification alongside their existing supply-chain and compliance review: confirming the distributor restricts sales to licensed professionals, confirming pricing is never published and is instead reserved for verified accounts, and confirming registration and licensure documentation is available to review on request rather than published as an unverified claim.
Clinics in this specialty often also ask how exosome products are regulated, since there are currently no FDA-approved exosome products and exosome products are generally handled as biologic drugs under section 351 of the Public Health Service Act. Precision Biologics shares that regulatory framing directly rather than leaving a clinic to piece it together.
Portland
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
160- Pain Medicine
- 71
- Physical Medicine & Rehabilitation
- 89
Documentation a clinic should keep on file
Because each lot carries a unique identifier and is held in quarantine until internal release criteria and third-party sterility testing are complete, clinics can request and file lot-specific records rather than relying on a general product sheet.
- Certificate of analysis for the specific lot
- Donor eligibility summary
- Lot release record confirming quarantine and release criteria were met
- Supplier characterization data for exosome products, on request
Receiving cryopreserved and lyophilized shipments in the Pacific Northwest
Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and are stored at -80 degrees C until use; lyophilized formats ship shelf-stable and are handled per the insert supplied with the lot. A Portland clinic's intake process should confirm the shipment matches its lot identifier and log it at the patient record level for traceability.
Verify your regulatory posture independently
Whether a given intended use of a Wharton's jelly or exosome product fits a clinic's regulatory framework is a question for the clinic's own counsel and, where relevant, the Oregon Medical Board, not something a supplier should resolve for a buyer. Precision Biologics supports account verification, documentation requests, and physician-level calls about that documentation, but does not provide clinical or legal advice.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Are exosome products FDA-approved?+
No. The FDA has stated there are no FDA-approved exosome products, and exosome products are generally regulated as biologic drugs. Clinical use decisions rest with the treating physician and the clinic's own regulatory counsel.
How does Precision Biologics verify a Portland pain management practice before opening an account?+
Accounts are verified through the practice's NPI number and limited to licensed professionals; pricing is never published and is only shared with verified accounts.
What should our clinic ask for before accepting a shipment?+
Request the lot-specific certificate of analysis and confirm the shipment's lot identifier matches your paperwork before logging it into inventory.